||National and international experts will meet at the National Institutes of Health (NIH) on April 23-25, 2001, to present new findings on the biology, epidemiology, and treatment of AIDS-related cancers, including Kaposi's sarcoma, lymphoma, and anal and cervical cancers. Sponsored by the National Cancer Institute (NCI), this annual meeting provides a state-of-the-art overview of knowledge about these malignancies, which have emerged as an epidemic within the larger AIDS epidemic.
This year's meeting includes a special virology component focusing on the viruses associated with AIDS-related cancers, including human herpesvirus 8, human papillomavirus, and Epstein-Barr virus. Presenters will discuss the latest information on mechanisms of viral oncogenesis and immune evasion, and on innovative approaches to treatment. Roundtables of experts will discuss the most recent data from a variety of pre-clinical animal models for AIDS cancers, advances in therapeutic and prophylactic vaccines for treatment and prevention of anogenital cancers, and ongoing and planned clinical trials from the AIDS Malignancy Consortium, a network of investigators across the United States conducting clinical trials for AIDS-related cancers. In addition, this meeting includes a new session focused on genomics, proteomics and bioinformatics.
Sara Rowland-Jones, D.M., John Radcliffe Hospital, U.K.
Ian Frazer, M.D., University of Queensland, Australia
Lou Staudt, M.D., Ph.D., NCI
Riccardo Dalla Favera, M.D., Columbia University
Thomas Quinn, M.D., Johns Hopkins University/ NIAID
Anthony Nash, Ph.D., University of Edinburgh, Scotland